A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide

Clinical trial NCT06844383 · RECRUITING

Trial details

NCT number: NCT06844383
Sponsor: Prostate Cancer Clinical Trials Consortium
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer (Adenocarcinoma)mCRPC (Metastatic Castration-resistant Prostate Cancer)

Start date: 2026-05-04
Primary completion: 2029-03-01
Enrollment: 126

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.